New anti-VEGF therapy shows promise in Phase 1 Clinical trial
anti-VEGF

New anti-VEGF therapy shows promise in Phase 1 Clinical trial

The new drug is manufactured by 4D Molecular Therapeutics and is a dual-transgene intravitreal gene therapy.
One neovascular AMD treatment more effective than the other
AMD

One neovascular AMD treatment more effective than the other

A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.
Eye implant to treat wet macular degeneration approved by FDA
AMD

Eye implant to treat wet macular degeneration approved by FDA

The device is the size of a grain of rice and is refilled every six months.
Study indicates some patients may be "weaned" off injections for wet macular degeneration
age-related macular degeneration

Study indicates some patients may be "weaned" off injections for wet macular degeneration

Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.
Gene Therapy for Macular Degeneration positive results
age-related macular degeneration

Gene Therapy for Macular Degeneration positive results

For patients suffering from age-related macular degeneration, gene therapy has the potential to transfigure the treatment options that are available.
New Anti-VEGF treatment has positive results in first clinical trial
age-related macular degeneration

New Anti-VEGF treatment has positive results in first clinical trial

EyePoint Pharmaceuticals recently announced results of the Phase 1 clinical trial of their new wet age-related macular degeneration treatment, EYP-1901.
Port Delivery System therapy looking for FDA approval
age-related macular degeneration

Port Delivery System therapy looking for FDA approval

The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.
5 Eye Diseases that can lead to Blindness
age-related macular degeneration

5 Eye Diseases that can lead to Blindness

There are five eye diseases that are the leading causes of blindness and low vision in the United States: age-related macular degeneration, cataracts, glaucoma, diabetic retinopathy and eye injurie...
Parkinson's drug may be a treatment for advanced age-related macular degeneration
AMD

Parkinson's drug may be a treatment for advanced age-related macular degeneration

Researchers discovered that levodopa is safe, well-tolerated and not only improved visual outcomes but also delayed anti-VEGF injections.